Medicure Inc. (CVE:MPH – Get Free Report) shares reached a new 52-week low during trading on Monday . The stock traded as low as C$0.65 and last traded at C$0.65, with a volume of 7000 shares changing hands. The stock had previously closed at C$0.68.
Medicure Trading Down 4.4 %
The company has a quick ratio of 1.29, a current ratio of 2.03 and a debt-to-equity ratio of 4.65. The business’s fifty day moving average is C$0.79 and its two-hundred day moving average is C$0.87. The firm has a market cap of C$6.78 million, a price-to-earnings ratio of -3.34 and a beta of 0.90.
Medicure Company Profile
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Further Reading
- Five stocks we like better than Medicure
- What Does a Stock Split Mean?
- Options Activity Points to More Volatility for Palantir Stock
- What is the Nasdaq? Complete Overview with History
- NVIDIA Stock: Oversold, Undervalued — How Low Can It Go?
- What is the S&P/TSX Index?
- MicroStrategy Sees Insider Buy-Sell Action in Q1
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
